Covid-19 vaccine winners suffer reversal of fortune

'At the height of the pandemic, investors clamoured to buy vaccine makers, the closest thing to a sure bet.

'Shares in Pfizer, which developed a vaccine and an antiviral drug, have plummeted 46 per cent from their peak in late 2021, while its German vaccine partner BioNTech is down 75 per cent and rival Moderna has plunged 79 per cent.

'Less successful vaccine makers have fallen back even more significantly: shares in Novavax, whose Covid shot has sold far fewer than the messenger RNA jabs, have fallen 97 per cent since early 2021.'

https://finance.yahoo.com/m/df1f80b4-6b86-3dbb-a5cf-9dc2f42988c4/covid-19-vaccine-winners.html

Covid-19 vaccine winners suffer reversal of fortune

At the height of the pandemic, investors clamoured to buy vaccine makers, the closest thing to a sure bet. Shares in Pfizer, which developed a vaccine and an antiviral…